Wolverine Asset Management »

Cerevel Therapeutics Hldng I shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 29k 40.89
2024-03-31 $1.2M 29k 42.27
2023-12-31 $12M 277k 42.40
2023-09-30 $6.1M 277k 21.83
2023-06-30 $7.8M 245k 31.79
2023-03-31 $5.9M 242k 24.39
2022-12-31 $6.2M 197k 31.54
2022-09-30 $3.8M 136k 28.26
2021-06-30 $313k 12k 25.54
2021-03-31 $120k 8.8k 13.67

More positions owned by Wolverine Asset Management

Lucid Group Com New Put Option (LCID)
Strategy Cl A New Call Option (MSTR)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Iren Ordinary Shares Put Option (IREN)
Strategy Note 0.625% 9/1 (Principal)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Rivian Automotive Com Cl A Call Option (RIVN)
Sea Note 2.375%12/0 (Principal)
Coinbase Global Com Cl A Call Option (COIN)
Rocket Lab Corp Put Option (RKLB)
Nio Spon Ads Put Option (NIO)
Meta Platforms Cl A Call Option (META)
Marathon Digital Holdings In Call Option (MARA)

View all positions for Wolverine Asset Management